The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Objective
This exploratory analysis examined the effects of intensive behavioral therapy (IBT) for obesity (“IBT‐alone”), IBT plus liraglutide 3.0 mg/d (“IBT‐liraglutide”), and IBT plus liraglutide 3.0 mg/d plus 12 weeks of a portion‐controlled diet that provided 1,000 to 1,200 kcal/d (“Multicomponent”) on changes in food cravings, eating behaviors, and eating disorder psychopathology at 24 and 52...
This study examined the effects of intensive behavioural therapy (IBT) for obesity (IBT‐alone), IBT plus liraglutide 3.0 mg/day (IBT‐liraglutide), and IBT‐liraglutide combined with 12 weeks of a portion‐controlled diet (Multicomponent) on changes in general health‐related (HR) quality of life (QoL) and weight‐related QoL. Adults with obesity (79.3% female; 54.0% white; 44.7% black; mean age = 47.6...
Objective
This study examined what adults with binge‐eating disorder (BED) and obesity perceived as the threshold for a large amount of food and how their evaluations compared to ratings by participants with obesity but without BED.
Method
This was a cross‐sectional study of 150 participants with obesity. BED was assessed using the Questionnaire on Eating and Weight Patterns and confirmed via interview...
Objective
The Centers for Medicare and Medicaid Services (CMS) covers intensive behavioral therapy (IBT) for obesity. The efficacy, however, of the specific approach has never been evaluated in a randomized trial, as described here. The 1‐year trial also assessed whether the addition to IBT of liraglutide 3.0 mg would significantly increase weight loss and whether the provision of meal replacements...
Objective
The objective of this study was to determine the effects of weight loss and weight loss maintenance (WLM) on weight‐specific health‐related quality of life in a 66‐week trial.
Methods
Adults with obesity (N = 137, 86.1% female, 68.6% black, mean age = 46.1 years) who had lost ≥ 5% of initial weight in a 14‐week intensive lifestyle intervention/low‐calorie diet (LCD) program were randomly...
Objective
Improving the maintenance of lost weight remains a critical challenge, which can be addressed by long‐term behavioral and/or pharmacological interventions.
Methods
This study investigated the efficacy of combined behavioral and pharmacological treatment in facilitating weight loss maintenance (WLM) in 137 adults (86.1% female; 68.6% black; BMI = 37.0 ± 5.6 kg/m2) who had lost ≥ 5% of...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.